Pyxis Oncology
Jason J. Luke is on the Board of Advisors at Pyxis Oncology.
This person is not in the org chart
This person is not in any offices
Pyxis Oncology
2 followers
Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.